Kolexia
Raymond Stephanie
Biologie médicale
Hôpital Purpan
Toulouse, France
85 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à VIH COVID-19 Séropositivité VIH Infections à papillomavirus Co-infection Démence associée au SIDA Thyréotoxicose Hépatite Hépatite B

Industries

Gilead
9 collaboration(s)
Dernière en 2023
MSD
5 collaboration(s)
Dernière en 2023
ViiV Healthcare
4 collaboration(s)
Dernière en 2023
OVERCOME
2 collaboration(s)
Dernière en 2021

Dernières activités

Human papillomavirus testing using HPV APTIMA® assay and an external cellularity control in self-collected samples.
Journal of medical virology   16 décembre 2023
DORAVIR: A French national survey of people with HIV-1 treated by an antiretroviral regimen including Doravirine
HIV medicine Congress 2023   01 décembre 2023
SARS-CoV-2 Co-Infections and Recombinations Identified by Long-Read Single-Molecule Real-Time Sequencing.
Microbiology spectrum   01 juin 2023
Whole-genome single molecule real-time sequencing of SARS-CoV-2 Omicron.
Journal of medical virology   28 février 2023
Influence of Nasopharyngeal Viral Load on the Spread of the Omicron BA.2 Variant.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America   10 février 2023
HIV-1 resistance genotyping by ultra-deep sequencing and 6-month virological response to first-line treatment.
The Journal of antimicrobial chemotherapy   02 février 2023
Whole-genome sequencing of SARS-CoV-2: Comparison of target capture and amplicon single molecule real-time sequencing protocols.
Journal of medical virology   12 septembre 2022
Influence of immune escape and nasopharyngeal virus load on the spread of SARS-CoV-2 Omicron variant.
The Journal of infection   07 février 2022
Influence of the Delta Variant and Vaccination on the SARS-CoV-2 Viral Load.
Viruses   04 février 2022
Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey.
The Journal of antimicrobial chemotherapy   28 octobre 2021